TriSalus Life Sciences【TLSI】株式ニュース

名称	銘柄コード	市場	種別
TriSalus Life Sciences Inc	TLSI	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.15	1.55%	9.85	09:00:00

始値	安値	高値	終値	前日終値
9.56	9.52	9.89	9.85	9.70

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/15	21:00	BW	TriSalus Reports Q1 2024 Financial Results and Business..
2024/5/07	20:00	BW	TriSalus Life Sciences Appoints Liselotte Hyveled to its..
2024/5/07	05:58	BW	TriSalus Life Sciences to Host First Quarter 2024 Financial..
2024/5/01	05:35	BW	TriSalus Life Sciences Secures up to $50 million of Debt..
2024/4/01	21:00	BW	TriSalus Reports Q4 and Full Year 2023 Financial Results and..
2024/3/26	21:00	BW	TriSalus Life Sciences Technology Featured in Two..
2024/3/21	21:00	BW	TriSalus Life Sciences Announces Oral Presentations at the..
2024/3/12	06:15	BW	TriSalus Life Sciences Announces Q4 Conference Call and..
2024/3/07	21:00	BW	TriSalus Life Sciences Receives Approval from the World..
2024/2/29	21:00	BW	TriSalus Life Sciences Announces Real-World Data..
2024/2/15	08:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/15	08:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/15	08:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/15	08:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/15	08:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	07:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/26	07:23	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/26	07:21	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/26	07:19	EDGAR2	Form 8-K - Current report
2024/1/06	06:28	EDGAR2	Form 8-K - Current report
2023/12/27	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2023/12/27	07:28	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/27	07:27	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/14	22:00	BW	TriSalus Reports Third Quarter 2023 Financial Results and..
2023/11/08	06:05	BW	TriSalus Life Sciences to Host Third Quarter 2023 Financial..
2023/11/05	03:25	BW	Late-Breaking Phase 1 Liver Metastasis Data from TriSalus..
2023/11/04	01:00	BW	TriSalus Life Sciences Presents Data for SD-101 Delivered by..
2023/10/25	22:05	BW	TriSalus Life Sciences Announces Late Breaker and Additional..
2023/10/19	10:58	EDGAR2	Form S-1/A - General form for registration of securities..
2023/10/17	06:23	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2023/10/03	19:01	EDGAR2	Form 8-K - Current report
2023/9/06	20:00	BW	TriSalus Life Sciences Appoints Jodi Devlin as President of..
2023/9/02	05:47	EDGAR2	Form S-1/A - General form for registration of securities..
2023/9/02	05:01	EDGAR2	Form 8-K - Current report
2023/9/01	10:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/01	10:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/9/01	06:22	EDGAR2	Form S-1 - General form for registration of securities under..
2023/8/29	21:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2023/8/22	05:33	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
2023/8/17	05:37	EDGAR2	Form 8-K - Current report